Biopharmaceutical Cmo And Cro Market Scope And Analysis

  • Report Code : TIPRE00007162
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analisi dell'ambito di mercato e dei concorrenti di CMO e CRO biofarmaceutici entro il 2025-2031

Buy Now

Biopharmaceutical CMO and CRO Market Report Biopharmaceutical CMO and CRO Market Size and Share Biopharmaceutical CMO and CRO Market Scope and Analysis

Biopharmaceutical CMO and CRO Market Report Scope

Report Attribute Details
Market size in XX milioni di dollari USA nel 2024
Market Size by XX milioni di dollari entro il 2031
Global CAGR ()
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Fonte
  • mammifero
  • non mammifero
By Tipo di servizio
  • produzione a contratto
  • ricerca a contratto
By Prodotto
  • farmaci biologici
  • biosimilari
  • vaccini
By Geografia
  • Nord America
  • Europa
  • Asia-Pacifico
  • Sud e Centro America
  • Medio Oriente e Africa
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AGC Biologics
  • Boehringer Ingelheim International GmbH
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • TOYOBO CO., LTD
  • JRS PHARMA
  • Lonza
  • PRA Health Sciences, Inc.
  • ProBioGen AG
  • Rentschler Biopharma SE